- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:01 | FANGZHOU JIANKE (06086): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| So | FANGZHOU JIANKE (06086): CHANGE OF CHAIRMAN, CHIEF EXECUTIVE OFFICER AND AUTHORISED REPRESENTATIVE; RE-DESIGNATION OF DIRECTOR; CHANGE IN THE COMPOSITION ... | - | HKEx | ||
| 27.11. | Fangzhou Inc.: Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management | 10 | GlobeNewswire (USA) | ||
| 08.11. | Fangzhou Inc.: Fangzhou Awarded "Golden Bull Award" for Leadership in AI-Powered Chronic Disease Management | 1 | GlobeNewswire (USA) | ||
| 07.11. | Fangzhou Inc.: Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE | 503 | GlobeNewswire (Europe) | SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, was invited to the "Boundless... ► Artikel lesen | |
| FANGZHOU Aktie jetzt für 0€ handeln | |||||
| 02.11. | Fangzhou Inc.: Fangzhou's "XingJie" LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations | 1 | GlobeNewswire (USA) | ||
| 29.10. | Fangzhou Inc.: Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management | 198 | GlobeNewswire (Europe) | SHANGHAI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai Fosun Pharmaceutical (Group)... ► Artikel lesen | |
| 26.09. | Fangzhou Inc.: Fangzhou's 'XingShi' LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care | 1 | GlobeNewswire (USA) | ||
| 25.09. | FANGZHOU JIANKE (06086): 2025 INTERIM REPORT | - | HKEx | ||
| 18.09. | Fangzhou Inc.: Fangzhou Named 'Outstanding Growth Story in Hong Kong Stocks' at China Capital Market Development Forum 2025 | 1 | GlobeNewswire (USA) | ||
| 18.09. | Fangzhou Inc.: Fangzhou Wins Gilead 'Award of Excellence' for AI-Driven Chronic Disease Management | 13 | GlobeNewswire (USA) | ||
| 15.09. | FANGZHOU JIANKE (06086): ANNOUNCEMENT MADE PURSUANT TO RULE 13.10 OF THE LISTING RULES | - | HKEx | ||
| 14.09. | Fangzhou Inc.: Fangzhou Unveils "XingShi" LLM to Advance AI-Driven Chronic Disease Management | 2 | GlobeNewswire (USA) | ||
| 10.09. | Fangzhou Inc.: Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions | 375 | GlobeNewswire (Europe) | SHANGHAI, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, signed a strategic partnership with Innovent... ► Artikel lesen | |
| 03.09. | Fangzhou Inc.: Fangzhou Secures 2nd National Science Foundation Project Approval, Deepens AI-Driven Healthcare Research | 2 | GlobeNewswire (USA) | ||
| 27.08. | Fangzhou Inc.: Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand | 369 | PR Newswire | HONG KONG, Aug. 27, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported... ► Artikel lesen | |
| 27.08. | FANGZHOU JIANKE (06086): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 3 | HKEx | ||
| 15.08. | FANGZHOU JIANKE (06086): DATE OF BOARD MEETING | - | HKEx | ||
| 21.07. | Fangzhou and Novo Nordisk link on chronic disease management | 44 | Pharmaceutical Technology | ||
| 21.07. | Fangzhou And Novo Nordisk Collaborate To Combat Chronic Diseases | 45 | RTTNews |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 43,510 | +1,92 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,040 | +0,08 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | +1,21 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| FRESENIUS | 47,720 | -0,60 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 158,96 | -1,85 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 29,380 | -2,07 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | +2,65 % | Nutex Health extends share repurchase plan | ||
| GERRESHEIMER | 25,860 | -1,52 % | INDEX-MONITOR: JPMorgan erwartet Aumovio im MDax - Dax wohl unverändert | FRANKFURT (dpa-AFX) - Im Dax dürfte zur Index-Überprüfung an diesem Mittwoch alles beim Alten bleiben. Eine Änderung erwartet die US-Bank JPMorgan dagegen im Index der mittelgroßen Unternehmen, die... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 9,310 | +1,92 % | Aveanna Healthcare stock price target raised to $13 by Raymond James | ||
| CARL ZEISS MEDITEC | 43,440 | +0,32 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| CERIBELL | 19,720 | +2,98 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| GOODRX | 2,710 | -1,45 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? |
Das Unternehmen FANGZHOU INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,306 Euro und damit -1,29 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FANGZHOU INC finden Sie auf Wallstreet Online.